FILING ANALYSIS · FRIDAY, NOVEMBER 13
Tempest Therapeutics, Inc. TPST — 8-K: Results of Operations and Financial Condition
negative
The company announced a private placement with gross proceeds of approximately $2.5 million and an equity line of credit with Lincoln Park Capital Fund of up to $50.0 million, which may lead to dilution, and reported a decrease in cash and cash equivalents to $0.9 million
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →